chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The day before I tested positive for COVID-19, I had a headache and runny, stuffy nose, which I attributed to allergies. The following morning, on 12/10/2022, I had the same symptoms, but I had fever and general malaise. I took a home antigen test and got a positive result. I was in disbelief, so I tested two more times and got two more positive results. The next day, I called my doctor and told him I had tested positive. He prescribed me Paxlovid, which I began taking that evening. The next day, I had horrible diarrhea and a nasty taste in my mouth. The diarrhea lasted for three days, and the aftertaste lasted as long as I took the Paxlovid. I then got a bit of a low-grade fever that lasted two days and then went away. By day three, I felt better. I was still run-down, but I no longer had diarrhea or fever. I was able to function, though. I also took more naps than usual. By day five, I felt pretty good, though I was still testing positive. On 12/20/2022, I finally tested negative for COVID-19. I also tested negative on 12/21/2022. However, I tested positive again on 12/23/2022, 12/24/2022, and 12/25/2022. Then on 12/26/2022, 12/27/2022, and 12/28/2022, I tested negative. On 1/1/2023, I tested again, because I had the sniffles, but the result was negative. On account of my hereditary angioedema, I was in isolation from 12/10/2022 until 1/5/2023. On 1/4/2023, I took a home antigen test and got a negative result. I then took a PCR test on 1/5/2023 at the infusion center, and it also came back negative. Afterwards, I was able to come out of isolation.
Sudden hearing loss in Left Ear -15 db to -55 db depending on frequency. Most loss in 500Hz to 1000Hz range.  Visited 2 ENT Dr for audiology tests.  Recommendation/prescription 60mg daily Prednisone tablets for 7 days, 40mg daily for next 3 days, 20mg for 3 days followed by 10mg for 3 days.
Pt returned 3 days after injection to show RPh a dollar size rectangle red area. The center had a half dollar (coin) size yellow/pale area. Not painful. OTC pain med & or BENADRYL suggested.
Patient was shaking and had a high blood pressure. Vitals were normal upon arrival of paramedics, but was taken to the hospital for further observation.
red rash on lower inner sides of feet, and toes; Psoriasis patch on eyeline; This is a spontaneous report from a contactable consumer (Patient). An elderly non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EN6201), Solution for injection, via an unspecified route of administration, administered in Arm Right on 18Feb2021 13:00 as single dose for covid-19 immunisation. Medical history included osteoarthritis, blepharitis, angle closure glaucoma, colitis, psoriasis and latex sensitivity allergy. There were no concomitant medications. Patient did not receive any other vaccine with four weeks of Pfizer vaccine. He did not receive any other medication in two weeks. Patient was not diagnosed with COVID-19 prior to receiving Pfizer vaccine. He was not tested for COVID-19 since vaccination. Patient historic vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EL3302) via an unspecified route of administration, administered in Arm Right on 28Jan2021 at 10:15 AM for COVID-19 immunisation. On 20Feb2021 23:00, the patient experienced red rash on lower inner sides of feet, and toes and psoriasis patch on eyeline. It was reported that patient had red rash on lower inner sides of feet, and toes. 1-1/2" band from heel to mid foot, also bottom of feet Psoriasis (?) patch or ?? raised bumps centered on lower back starting 2" below waistline on 3" long , 1-/2" wide and psoriasis patch on eyeline. The outcome of event was not recovered.   Follow-up attempts completed. No further information expected.
Inadvertent subcutaneous injection below deltoid, Pain in shoulder, swollen glands, muscle weakness  and pain, unable to lift arm and activate scapula. Diagnosed SIRVA. I have had several months of  physical therapy to regain strength in my left shoulder. I have had improvement but not 100% normal  (90%).
-Constant body aches - joint pain -fevers of 100.4 - headaches (occipital region) - fatigue - swollen lymph nodes on throat - dry cough -difficulty breathing (The first week this was especially bad, she would be gasping for air after taking just a few steps- we took her to the ER for this).  Currently she takes 1000mg of Tylenol every 6 hours, 375mg of Naproxen every 12 hours, and one pantoprazole a day.
Severe migraine for 4 days shooting pain in arm of injection site discomfort in eyes
[[address]]a ruling released Nov. 17. "The undersigned cannot based an onset on a chimera of transient toe tingling and numbness", special master said. "The onset here is not one month, not three months, far too [[name]] to be medically appropriate for a causative link with hepatitis B vaccine." Only acceptable diagnosis: "The only acceptable diagnosis of onset in this [[name]] is in 1996, two years after petitioner's third hepatitis B vaccination when she did see doctors and complained of recent onset (not numbness and tingling intermittently occurring over two years) and for which there was objective testing, and evidence of lesions occurring over space and time," the special master said. "This objective testing and evidence of lesions occurring over space and time is consonant with the [[name]] criteria, created by the most notable international neurologists as a template for the diagnosis of MS." According to the special master, the 47 year old patient said she had experienced tingling of the toes after her third hepatitis B vaccination on [[name]] 31, 1994. She mentioned it to a physician during a visit on 07-Sep-1994 which would in any [[name]] have been outside the two-month window special master set for MS causation in the omnibus proceeding. In September 1996, the patient consulted neurologist. A magnetic resonance imaging test showed multiple [[name]] white matter lesions consistent with demyelinating disease. Contrast enhancement of two [[name]] lesions was consistent with active lesions. Upon internal review, the multiple sclerosis (MS) was considered to be an other important medical event. No further information is expected.
Headaches on a regular basis. Did not suffer headaches before last shot. Tired easily.
pt recv vax in 1996 & 6mo to 1yr later on 7FEB97 pt devel 75 lesions on neck, trunk, scalp, & face;By 13FEB97 most of the lesions had crusted but two new lesions were noted on back;
Chills, inability to get warm, vomiting, headache, uncontrollable shaking
Information has been received from a pharmacist referring to a 59 year old male patient with none pertinent medical history and none drug reactions/allergies. On 13-OCT-2015 the patient was vaccinated with ZOSTAVAX (lot # L024997, expiration date: 06-OCT-2016, route and dose were unknown). On the same day, the patient experienced warmth and minor swelling at the injection site. The next day on 14-OCT-2015, the patient experienced a low-grade fever and body aches. The patient called the pharmacy for medical attention. No treatment was given for the events and no lab diagnostics studies were performed. The patient's low-grade fever resolved on 14-OCT-2015 however, the patient continued to experience the other symptoms. The causality was not reported. Additional information has been requested.
no adverse events; the patient was administered improperly stored dose of proquad on 04-06-2020; This spontaneous report was received from a nurse regarding a patient of unknown age and gender. The patient's medical history, historical drugs, drug allergies, concurrent conditions and concomitant medications were not reported.   On 04-JUN-2020, the nurse reported that the patient was administered an improperly stored dose of measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live (PROQUAD) (product storage error) (lot# S021324 and expiry date was reported as 05-JAN-2021; dose, route of administration and product indication were not reported) with properly stored DILUENT MRK Injection (lot# T003594 and expiry date was reported as 07-JUL-2022). The vaccine was stored at 21.4 Fahrenheit (F) for 2 hours. There was no previous temperature excursion. No adverse effect was reported. The call was because of data logger. No product quality complaint (PQC) was present.
Local reaction. Raised wheal 2.25 in (5.5 cm) in diameter, painful and reddened, appeared within 5 hours. Remains raised/painful >48 hours after injection. Ice applied periodically.
This spontaneous report was received from a pediatrician via a company representative and refers to an unspecified patient of an unknown age and gender. The patient had been fasting prior the office visit, for an unspecified period of time. The patient's medical history, historical drugs and concomitant therapies were not reported. In April 2018 (reported as "last week"), the patient was vaccinated with GARDASIL 9 intramuscularly (strength, dose, lot number and expiration date were not reported) for prevention of human papillomavirus (HPV). On the same date within the 30 seconds of administering the injection (April 2018), the patient experienced a seizure. It was unknown if treatment was given for the aforementioned event or if laboratory diagnostics or studies were performed. The outcome of seizure was unknown. The causal relationship between the event and GARDASIL 9 was not reported. There was no product quality complaint (PQC) reported. No further adverse event information was provided. Upon internal review, the event of seizure was considered to be serious due to medically significant. This is a non-valid case due to lack of patient identifier. Follow up information has been received on 07-MAY-2018. Upon receipt of follow-up information it was determined that this case is now valid because of availability of patient demographics. The reporter stated that the patient was 11 year old male. On 06-APR-2018, the patient was vaccinated with GARDASIL 9 for prophylaxis. At the same time the patient received co-suspect diphtheria toxoid, pertussis acellular vaccine (unspecified), tetanus toxoid (TdaP) (dose, frequency, route, lot number and expiry date not reported) for prophylaxis. On the same day, the patient experienced seizure manifested by syncope, temporary paralysis of arms and legs which was followed by amnesia. It was further stated that the patient fell back (fall) and hit his head on an unspecified object (head injury). It was also reported that after the event, the patient was transferred by ambulance to emergency room (ER) for evaluation. No treatment was given in ER. Patient was advised to follow up with a neurologist. The outcome of head injury was not reported. The relationship between the suspects and the events was not reported. No further information was provided. Upon follow up, it has been determined that case # US-009507513-1804USA010705 is a duplicate of case # US-009507513-1804USA010540. Therefore, case # US-009507513-1804USA010705 is being deleted from our files and the cases are consolidated into case # US-009507513-1804USA010540.
numbness, redness of 4cm @ inject site p/1st inject on 16JAN92; 23JAN92 2nd inject had black out spells; 6JUN92 had 3rd dose & exp numbness; 5MAR92 f/u recovered; blood draw for titer; no results given;
Mumps vaccine administered on 12-11-06 at 1100. Onset at 1700 of febrile seizure; 1800 Temp 102F. Fever chills, body aches, malaise, sore left upper arm, nausea. 12-12-06 mild swelling at site, tongue, digits, joint aches extreme malaise, sore throat, tenderness in anterior cervical nodes, migraine headache. Treated with Tylenol and Benadryl. Rest and increase fluids.
Patient reported by phone that she had "red blotches down the arm" from the injection site to the wrist. Reported no fever, pain, swelling or itching. Reported within 4 1/2 hrs of injection.
Around 12:54 pm, the father frantically carried him into the clinic.  Father passed the patient to me and I carried him into room 2 onto the table. He was slightly responsive but had foaming saliva around the mouth, and when his mother asked him to repeat his sister's name he repeated it. He was not in an respiratory distress. His father denied any seizures, but said he was almost passing out. Blood glucose was checked and it was 118 by MA. The patient responded to the fingerprick and cried normally. Pulse ox with portable finger oximetry was at 65-70% but that was rechecked with a child pulse oximetry which confirmed the low oxygen level. MA, brought the oxygen. Oxygen 10 L face mask was given. Because the patient did not like the face mask, we sat him up in his father's lap. We removed the oxygen and his oxygen level was more than 95%. However, then he lost consciousness for less than 10 seconds. No seizure activity. Once we moved him back to the table and put on oxygen he woke up again. That is when we noticed the hive over 5-7 cm oval next to the left leg injection site. Because he had a change in mental status, I decided to give epinephrine 0.15 mg SQ. The injection was given by RN at 1:03 pm.  911 was called by MA. After the injection, the patient's mental status returned to normal and he started talking. He face and body became flushed and there was mild swelling in the extremities.
The same night as the vaccine, I developed a fever greater than 101.5 and developed bad chills throughout entire  night. Could not sleep because of chills. Next morning, developed severe legs pains and deep muscle pain - both legs - both calves, both sides. Resulted in me having to miss that day of work. I called my Dr's office and they advised to go to ER for severe leg pain. I didn't because I had a pharmacist that I work with who had advised me that I could wait. Similar symptoms to when I got COVID (on Dec 28th). Did have the same moderate arm pain in location of vaccine. Fever stayed above 100 for 48 hours. And the chills went away after 12 hours.  Around the clock Tylenol that stated when I got the vaccine - 1000 mg every six hours scheduled. Fever resolved after 2 days. Chills after 12 hours. Leg pain from severe on 15th - to moderate pain next day and on 18th the pain is more mild. Pain in legs haven't resolved entirely but much better.
Pt developed an injection site reaction characterized by redness and swelling. Pt then developed a red macula measuring 6 X 6 cm at the injection site. The macula was visible as of 4 months post vax.
Patient developed vasculitic lesions on hands, feet, nose.  Autoimmune work up thus far has been negative. Lesions started about 2 weeks after vaccine.
After second dose had flu like symptom  after second day. 1-10.  severity   6.   Body ache ,head ache, chills, exhausted
Day after booster: fever, severe fatigue and throbbing headache. 10 days after booster: raised, itchy hives all over head/face/neck/pelvis and mild rash on arms/torso.
11-3-14, pt dx'd with Henoch-Schonlein purpura after receiving vaccines on 9-23-14.
Narrative:  Admission Date: Aug 20,2021 Discharge Date: Aug 22,2021 Condition of patient at discharge: Stable Primary Diagnosis during Admission/Treatment: Acute on Chronic Hypoxic Respiratory failure in setting of COVID 52 y.o. male with h/o stage IV fibrocystic sarcoidosis, PH (groups III and V), APLS on coumadin, M. Abscessus in 2016, PFO with paradoxial embolic R MCA stroke, DVT, OSA on CPAP, and chronic hypoxemic respiratory failure on 3L O2, presented to the Emergency Dept with SOB, CP and increased sputum production. Patient reported that during the past week he has had a gradual development of his symptoms. Original onset began when he thought he was developing heartburn due to his GERD. However, the next day, he began to develop a heaviness in his chest. Symptoms began to progress where he was developing DOE and the heaviness in his chest was present upon waking. Pt stated he was unsure of where he got covid and is currently vaccinated with Moderna x 2 (1/14/2021 and 2/11/2021). He denies fever, chills, n/v/d, constipation, hematuria, melena, hematochezia, urinary urgency, dysuria. While in the ED, CXR showed stable, chronic appearing pleural and parenchymal scarring. No active cardiopulmonary process. Additionally, labs showed COVID+, ultra CRP 0.44, BNP <100, INR-1.5, CPK-143, CPK-MB-2.7 and troponin <0.02. Current diagnosis of COVID pneumonia and required 4L of O2 an admission and saturation remained around 96%. The patient was admitted briefly and discharged 2 days later in stable condition.
Solitary macular, ring-like facial lesion noted the night following immunization, painless, nonpruritic.  No dyspnea, cough, other rash, N/V, or lip/throat/tongue swelling.  No other new exposures (animals, facial products, facial procedures).
56-year-old female 15 minutes post vaccine (Post Moderna booster vaccine) at 9:30 am client complained of "head spinning", Client stated no history of past vaccine reactions and no history of anxiety. Client states she has eaten this morning. Son used as interpreter. Nurse assisted in assessment of symptoms with blood pressure as first reading, 9:34 am BP: 62/42 RR: 48 HR: 52.  Nurse and son assist client to anti-gravity chair for further assessment and observation.  Client became diaphoretic and shaking. Instructed to deep breathe.  Son gave client (mom) sips of water per her request. 9:39 am, BP: 113/69 HR: 68.  Nurses continued to observe client for additional complications.  Client continues to tremble.  Next set of vital signs during observation: 9:43 am BP: 124/76 HR: 83. Client was given juice, breathing improved and less diaphoretic. Client continues to stay oriented x 4. Vital signs at 9:48 BP: 123/84 HR: 81 RR: 30.  Client verbalizes that she is "feeling better" and eyes feel heavy.  Client states she would like to go home. Last set of vitals before client is sent home: 9:53 am BP: 129/92 HR: 75 RR: 17.  Client left observation area on own steady gait.  Reviewed patient education with son instructing to call emergency services if symptoms return or worsen.
The morning following vaccination -pt reports soreness. By 11 am on this day soreness had grown worse. Grape- fruit sized redness developed around injection site. Today- day 2 after vaccination- redness and soreness persist.
Received Covid injection at 1530 and at 1800 the patient started having heart palpitations that lasted approximately 1.5 hours. At 1400 the day after the injection (10/26/2021) heart palpitations returned and lasted approximately 30 minutes
Patient became dizzy and weak immediately after receiving vaccinations.  No loss of consciousness. Patient immediately placed in trendelenburg position.  V/S:  BP 118/66, HR 60 (repeat HR after 3 minutes 70 BPM), R 16 unlabored, SPO2 97% RA.  HOB elevated in 30-degree intervals q 5minutes until patient sitting upright comfortably.  After demonstrating ability to tolerate small sips of water, pt repositioned with legs dangling from exam table, then assisted to standing position.  Able to ambulate without assistance.  Patient monitored for 20 minutes after event, then discharged to his mother.
26JAN97 temp 100.7, productive cough;med x 21 days 4FEB97;
Site sore and red, generalized muscle aches, headache, nausea, chills and T 100.8.
pt recv vax & devel redness,induration,warmth & pain @ inj site
After immunizations (5-10 minutes) pt went limp for few minutes - resolved then had generalized tonic/clonic seizure x 45 sec. Postictal few hours then prolonged crying at hospital.
Ringing in ear (mostly left ear) since (more or less) receiving the second dose of the Moderna Covid19 vaccine.
Patient had an erythematous maculopapular rash develop six days after receiving her vaccination. Rash is present on her trunk, thighs, and face with the rash coalescing on her back. No other notable symptoms.
Fever blisters presented in her mouth, on her lips and in her nose; vomited; felt pain all over her body; felt warm like a temperature but did not have one; like feeing like she had the flu; blisters in her mouth, on her lips and in her nose; very weak; This case was reported by a consumer via call center representative and described the occurrence of general body pain in a 74-year-old female patient who received Herpes zoster (Shingrix) for an unknown indication.   On 8th October 2020, the patient received the 1st dose of Shingrix. On 8th October 2020, less than a day after receiving Shingrix, the patient experienced general body pain, feeling of warmth and influenza-like symptoms. On 9th October 2020, the patient experienced vomiting and weakness. In October 2020, the patient experienced blister. On an unknown date, the patient experienced fever blister. The action taken with Shingrix was unknown. On 9th October 2020, the outcome of the general body pain was recovered/resolved. In October 2020, the outcome of the weakness was recovered/resolved. On an unknown date, the outcome of the feeling of warmth and vomiting were recovered/resolved and the outcome of the fever blister and blister were recovering/resolving and the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the general body pain, feeling of warmth, vomiting, weakness, fever blister, influenza-like symptoms and blister to be related to Shingrix.  Additional information was provided as follows: The patient felt warm like a temperature but did not have one, four to five hours after receiving the vaccine. At bedtime, she felt pain all over her body described like feeing like she had the flu. She hardly slept due to the pain everywhere. She was very weak and out of it the next morning and could hardly make it to the bathroom where she vomited.  The body pain lasted about 24 hours.  The weakness lasted a week.  Fever blisters presented in her mouth, on her lips and in her nose a few days after administration.  Those were resolving. The reporter consented to follow up.
Headache, Sedation, Myalgia, Fever, CHILLS AND ARM PAIN Narrative:
Patient reported fever, chills, headache and rash two weeks after dose of Tdap, was also receiving avalox for sinusitis PCP believed symptoms due to the vaccine and not the Avalox
Injection in R arm. Neurological reaction/nerve response. Paralysis in right side of face and right arm. Throat numb on right side. Hospital dx: stroke or Bell's palsy. Admit: 11/10-11/11. Within 30 mins-ER. 11/17/09 Medical records received for date 11/11/09. Neuro consult. DX:allergic rx to H1N1 vax. Presented w/ c/o getting H1N1 vax in rt. arm, within 5 min. felt cramping pain in rt. side neck, shoulder, itching rt. arm, rt.hand and rt. side face numbness, facial droop rt. side. Pt. went to ER, where sx began to resolve, but c/o HA. Consult today pt states sx resolved. Assessment: WNL
This is a spontaneous report from a contactable physician via sales representative. A 78-year-old female patient received a single dose of PREVNAR13,, lot J49847, expiry date MAR2016, NDC 0005 1971 02), via an unspecified route of administration in the right deltoid, on 01DEC2014. Relevant medical history included hyperlipidemia and hypertension from an unknown date and unknown if ongoing. Concomitant medications included CARTIA XT, RALOXIFENE, ATORVASTATIN. The patient experienced redness and swelling below the injection site on an unspecified date in DEC2014. The outcome of the reported events was unknown.
3 days after after second dose ? lots of itching , body rash for a month until I took Benadryl.  4 days after 3rd dose minor itching starting
Jaw pain, earache, knee joint pain, fatigue, chills, headache, loss of appetite, muscle pain
Pt received vaccine on 5/24/17 had large red patch with swelling on Rt arm. Mom reports high fevers. Mom was giving pt TYLENOL and MOTRIN for fever. Dr recommended BENADRYL.